Startups · AI

VP, Enterprise Sales

Hippocratic AI · United States · Remote

← All jobs
About Hippocratic AI

Hippocratic AI builds the safest generative AI healthcare agent for health systems, payors, and pharma. Over 180 million clinical interactions across 1,000+ use cases with 60+ partners worldwide. Backed by General Catalyst, Kleiner Perkins and a16z.

About the role

We are adding senior VPs of Enterprise Sales to our commercial team to land transformation deals at the largest health systems in the country.

What they're looking for

  • 15+ years selling enterprise software, services, or transformation engagements to health systems, with at least one role at a sub-500-person company
  • Experience personally closing $1M+ enterprise deals at health systems and consistent top tier performance
  • Proven ability to build an ROI model that withstands a CFO review and a clinical narrative that withstands a CMO review
  • Healthcare fluency. You can hold your own in a room with a CFO on margin pressure, with a CMO on clinical workflow, with a CIO on integration risk
  • Track record of selling into novel categories where the buyer did not have an existing budget line — digital health category creation, novel-mechanism pharma launches, transformation consulting, or equivalent
  • Trusted relationships with health system CIOs, CMOs, COOs, CDOs
More about this role

Hippocratic AI is the leading generative AI company in healthcare. We have the only system that can have safe, autonomous, clinical conversations with patients. We have trained our own LLMs as part of our Polaris constellation, resulting in a system with over 99.9% accuracy.

Reinvent healthcare with AI that puts safety first. We’re building the world’s first healthcare‑only, safety‑focused LLM — a breakthrough platform designed to transform patient outcomes at a global scale. This is category creation.

Work with the people shaping the future. Hippocratic AI was co‑founded by CEO Munjal Shah and a team of physicians, hospital leaders, AI pioneers, and researchers from institutions like El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google, Meta, Microsoft, and NVIDIA.

Backed by the world’s leading healthcare and AI investors. We recently raised a $126M Series C at a $3.5B valuation, led by Avenir Growth, bringing total funding to $404M with participation from CapitalG, General Catalyst, a16z, Kleiner Perkins, Premji Invest, UHS, Cincinnati Children’s, WellSpan Health, John Doerr, Rick Klausner, and others.

Build alongside the best in healthcare and...

Read the full posting on Hippocratic AI's site ↗

Sales & Marketing

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.